Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Interest & Investment Income: 2011-2021

Historic Interest & Investment Income for Abeona Therapeutics (ABEO) over the last 10 years, with Dec 2021 value amounting to $69,000.

  • Abeona Therapeutics' Interest & Investment Income rose 275.00% to $30,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $77,000, marking a year-over-year decrease of 80.80%. This contributed to the annual value of $69,000 for FY2021, which is 94.70% down from last year.
  • As of FY2021, Abeona Therapeutics' Interest & Investment Income stood at $69,000, which was down 94.70% from $1.3 million recorded in FY2020.
  • Abeona Therapeutics' Interest & Investment Income's 5-year high stood at $1.5 million during FY2018, with a 5-year trough of $69,000 in FY2021.
  • Its 2-year average for Interest & Investment Income is $685,000, with a median of $685,000 in 2020.
  • As far as peak fluctuations go, Abeona Therapeutics' Interest & Investment Income skyrocketed by 186.86% in 2018, and later tumbled by 94.70% in 2021.
  • Yearly analysis of 4 years shows Abeona Therapeutics' Interest & Investment Income stood at $525,000 in 2017, then skyrocketed by 186.86% to $1.5 million in 2018, then reached $1.3 million in 2020, then tumbled by 94.70% to $69,000 in 2021.